BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 20696752)

  • 1. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
    Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
    Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.
    Li N; Zhang F; Li S; Zhou S
    Biochem Biophys Res Commun; 2014 Feb; 444(4):611-6. PubMed ID: 24486548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
    Narita M; Shimura E; Nagasawa A; Aiuchi T; Suda Y; Hamada Y; Ikegami D; Iwasawa C; Arakawa K; Igarashi K; Kuzumaki N; Yoshioka Y; Ochiya T; Takeshima H; Ushijima T; Narita M
    PLoS One; 2017; 12(2):e0172115. PubMed ID: 28225782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
    Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
    Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
    Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
    Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
    Li J; Tan Q; Yan M; Liu L; Lin H; Zhao F; Bao G; Kong H; Ge C; Zhang F; Yu T; Li J; He X; Yao M
    Mol Cancer; 2014 Jul; 13():166. PubMed ID: 24997798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
    Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H
    Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
    Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
    Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
    Hurteau GJ; Carlson JA; Spivack SD; Brock GJ
    Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
    Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
    Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs.
    Farhan M; Malik A; Ullah MF; Afaq S; Faisal M; Farooqi AA; Biersack B; Schobert R; Ahmad A
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
    Shi H; Ji Y; Zhang D; Liu Y; Fang P
    Biochem Biophys Res Commun; 2015 Sep; 465(1):125-30. PubMed ID: 26235874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.